Alert

Clinical Trial Details Page

SWOG 1207

Objective

A Phase III Randomized, Placebo-controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One year of Everolimus in Patients with High-Risk Hormone Receptor-Positive and Her2Neu Negative Breast Cancer

IRB Protocol Number
NCT01674140

Clinical Trial Categories

  • Breast Cancer
Contact
Nancy Burns at 919-784-7209
or Nancy.Burns2@unchealth.unc.edu
How to Participate

View eligibility criteria and additional study information

Related Locations

Top